David P Schenkein sold $1.9M of Denali Therapeutics (DNLI)

Executed Nov 11 2024, disclosed Nov 13 2024, 2 days later.

Value, as filed

$1.9M

59,441 sh across 2 lots

Executed

Nov 11 2024

the trade date, as filed

Disclosed

Nov 13 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DS David P Schenkein Director profile →

David P Schenkein (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $1.9M of DNLI (59,441 sh across 2 lots, as filed), executed Nov 11 2024.

The name

DNLI Denali Therapeutics Inc. DNLI · Healthcare · 12 filings in 24 months ticker →

Healthcare · Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→